Organon & financials
$13.74+0.07%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.56B | $1.46B | $1.51B | $1.60B | $1.59B | $1.51B | $1.59B | $1.58B | $1.61B | $1.62B | $1.60B | $1.52B |
| Gross profit | $847.0M | $783.0M | $741.0M | $857.0M | $874.0M | $841.0M | $896.0M | $923.0M | $939.0M | $957.0M | $915.0M | $907.0M |
| Gross margin | 54.4% | 53.6% | 49.2% | 53.5% | 54.8% | 55.6% | 56.3% | 58.3% | 58.4% | 59.0% | 57.3% | 59.7% |
| Operating income | $322.0M | $235.0M | -$91.0M | $358.0M | $324.0M | $233.0M | $288.0M | $339.0M | $371.0M | $376.0M | $254.0M | $232.0M |
| Net income | $108.0M | $146.0M | -$205.0M | $160.0M | $145.0M | $87.0M | $109.0M | $359.0M | $195.0M | $201.0M | $546.0M | $58.0M |
| Net margin | 6.9% | 10.0% | −13.6% | 10.0% | 9.1% | 5.8% | 6.8% | 22.7% | 12.1% | 12.4% | 34.2% | 3.8% |
| Diluted EPS | $0.40 | $0.55 | $-0.78 | $0.61 | $0.56 | $0.33 | $0.42 | $1.38 | $0.75 | $0.78 | $2.13 | $0.23 |
| EBITDA | $402.0M | $352.0M | $313.0M | $450.0M | $415.0M | $403.0M | $373.0M | $408.0M | $437.0M | $464.0M | $372.0M | $293.0M |
| Operating cash flow | $107.0M | $225.0M | $141.0M | $264.0M | $220.0M | $75.0M | $390.0M | $141.0M | $332.0M | $76.0M | $397.0M | $261.0M |
| Free cash flow | $65.0M | $188.0M | $96.0M | $218.0M | $181.0M | $43.0M | $335.0M | $99.0M | $300.0M | $30.0M | $318.0M | $206.0M |
| Diluted shares | 270.4M | 262.9M | 261.2M | 260.7M | 260.2M | 261.0M | 259.9M | 259.8M | 258.6M | 258.4M | 256.6M | 256.3M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $1.13B | $1.12B | $574.0M | $672.0M | $599.0M | $547.0M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $8.55B | $8.57B | $8.64B | $8.83B | $8.90B | $8.96B |
| Total assets | $13.18B | $13.00B | $12.87B | $13.55B | $13.50B | $13.16B |
| Total liabilities | $12.17B | $12.09B | $12.12B | $12.65B | $12.77B | $12.61B |
| Shareholders' equity | $1.01B | $903.0M | $752.0M | $906.0M | $733.0M | $542.0M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology